Posted by Michael Wonder on 20 Feb 2020
FDA announces collaborative review of scientific evidence to support associations between genetic information and specific medications
20 February 2020 - Pharmacogenetic testing is a type of genetic test that in some instances can predict how a person will respond to specific medications.
Thus, this type of testing offers promise for informing the selection or dosing of some medications for certain individuals. When there is sufficient scientific evidence demonstrating a relationship between how a person’s genes may impact their metabolism of a drug or how they may respond to the drug, this information can be useful for health care providers.
However, for many medications, there is not sufficient scientific evidence to support using pharmacogenetic test results to inform prescribing decisions.
